HCPCS Level IIdrugActive
J7682
Tobramycin non-comp unit
BETOS: D1G
Effective: 2007-01-01
Referenced in 2 policies
Description
Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tobramycin
Manufacturer
Teva Pharmaceuticals USA, Inc.
HCPCS Dosage
300 MG
Billing Units
1.0000
21
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.